Sharath Burugina Nagaraja, MBBS, MD


Faculty
Department of Community Medicine
ESIC Medical College and PGIMSR
Rajajinagar
Bangalore 560010, Karnataka, India

Biography

Dr. Nagaraja, MBBS, MD is currently faculty in the Department of Community Medicine at ESIC Medical College and PGIMSR, Rajajinagar, Bangalore, India. Eariler, he has worked at World Health Organization (WHO) as National Consultant for Revised National Tuberculosis Control Programme (RNTCP) and has rich experience of Public Health (2006-2013). He has immensely contributed to the field of tuberculosis programme implementation; especially in the areas of drug resistant TB, TB and HIV, TB and diabetes and pediatric tuberculosis. Besides, he is trained in Operational Research at the Union, Paris and is a renowned facilitator for International and National Operational Research courses. He has more than 65 publications in international and national journals indexed in PubMed / MedLine to his credit. Most of his publications aimed at bringing change in policy and practice. He has also presented several papers at world lung conferences and was a guest speaker at National TB Conferences. Many guest lectures at state level conferences and medical colleges across the country has been delivered by him. In addition, he has contributed on devising a training module on Screening of Tuberculosis Patients for Diabetes Mellitus and HIV/TB guidelines on National Framework for joint HIV/TB collaborative activities for Ministry of Health and Family Welfare, Government of India. He is a competent public health expert, a competent teacher, and has proved to be a worthy academician.

Research Interest

His research interest includes: Public Health.

Scientific Activities

Publications

1. Srinath S, Sharath B, Santosha K, et al . Tuberculosis retreatment others: profile and treatment outcomes in the state of Andhra Pradesh, India. International Journal of Tuberculosis and Lung Diseases. 2011; 15(1): 105-109.
2. Pothukuchi M1, Nagaraja SB, Kelamane S, et al. Tuberculosis Contact Screening and Isoniazid Preventive Therapy in a South Indian District: Operational Issues for Programmatic Consideration. PloS One. . 2011; 6(7): e22500. doi: 10.1371/journal.pone.0022500
3. Burugina Nagaraja S1, Satyanarayana S, Chadha SS, et al. How do patients who fail first-line TB treatment but who are not placed on an MDR-TB Regimen Fare in South India? PloS One. 2011; 6(10): e25698 doi: 10.1371/journal.pone.0025698
4. Chadha SS, Sharath BN, Reddy K, et al. Operational challenges in diagnosing Multi-drug resistant TB and initiating treatment in Andhra Pradesh, India. Plos One. November 201; 6(11): e26659. doi: 10.1371/journal.pone.0026659
5. Satyanarayana S, Nagaraja SB, Kelamane S, et al. Did successfully treated pulmonary tuberculosis patients undergo all follow-up sputum smear examinations? . Public Health Action. . 201; 1(2): 27-29. doi: 10.5588/pha.11.0013
6. Kondapaka KK1, Prasad SV, Satyanarayana S, et al. Are Tuberculosis Patients in a Tertiary Care Hospital in Hyderabad, India Being Managed According to National Guidelines? Plos One. 2012; 7(1): e30281: doi: 10.1371/journal.pone.0030281
7. Zachariah R, Harries AD, Srinath S, et al. Language in tuberculosis services: when will we change the dogma and stop blaming our patients? – An appeal to the Global Stop-TB partnership. International Journal Tuberculosis Lung Diseases. 2012; 16(6): 714-717. doi: 10.5588/ijtld.11.0635
8. Paul D, Busireddy A, Nagaraja SB, et al. Factors Associated with Delays in Treatment Initiation after Tuberculosis Diagnosis in Two Districts of India. PloS ONE. 2012; 7(7): e39040. doi: 10.1371/journal.pone.0039040
9. Achanta S, Kumar AM, Nagaraja SB, et al. Feasibility and Effectiveness of Provider Initiated HIV Testing and Counseling of TB Suspects in Vizianagaram District, South India . PLoS ONE. 7(7): e41378. doi: 10.1371/journal.pone.0041378
10. Sachdeva KS1, Nagaraja SB, Kumar A, Kumar P, Ramachandran R.Certification of TB culture and drug susceptibility testing laboratories through the Revised National Tuberculosis Control Programme (RNTCP). Journal of Indian Medical Association. 2012; 110(7): 488-489.
11. Nagaraja SB1, Kumar AM, Sachdeva KS, et al. Is One Sputum Specimen as Good as Two during Follow-Up Cultures for Monitoring Multi Drug Resistant Tuberculosis Patients in India? . Plos one. 2012; 7(9): e45554. doi: 10.1371/journal.pone.0045554
12. Kumar A, Gupta D, Nagaraja SB, et al. Updated current (2012) national guidelines for paediatric tuberculosis in India. Journal of Indian Medical Association. 2012; 110(11): 840-843, 845.
13. Satyanarayana S, Kumar AMV, Sharath BN, Harries AD. Fast-track writing of a scientific paper with 30 authors: how to do it? Public Health Action. 2012; 2(4): 186–187.doi:10.5588/pha.12.0084
14. kumar A, Gupta D, Nagaraja SB, singh V, Sethi GR, Prasad J. Updated National Guidelines for Pediatric Tuberculosis in India, 2012. Indian Pediatrics. 2013; 50.
15. India Diabetes Mellitus–Tuberculosis Study Group.Screening of patients with diabetes mellitus for tuberculosis in India. Tropical Medicine and International Health. 2013; 18(5): 646-654. doi: 10.1111/tmi.12083
16. ndia Tuberculosis-Diabetes Study Group. Screening of patients with tuberculosis for diabetes mellitus in India. Tropical Medicine and International Health. 2013; 18(5): 636-645. doi: 10.1111/tmi.12084
17. Basnet R, Shrestha BR, Nagaraja SB, Basnet B, Satyanarayana S, Zachariah R. Universal health coverage in a regional Nepali hospital: who is exempted from payment?. Public Health Action. 2013; 3(1): 90–92. doi: 10.5588/pha.12.0082
18. Khann S, Mao ET, Rajendra YP, Satyanarayana S, Nagaraja SB, Kumar AM. Linkage of Presumptive Multidrug Resistant Tuberculosis (MDR-TB) Patients to Diagnostic and Treatment Services in Cambodia. Plos one. 2013; 8(4): e59903. doi: 10.1371/journal.pone.0059903
19. Achanta S, Jaju J, Kumar AM, et al. Tuberculosis management practices by Private Practitioners in Andhra Pradesh, India. Plos one. 2013; 8(8): e71119. doi: 10.1371/journal.pone.0071119
20. Shastri S, Sathyanarayna S, Nagaraja SB, Kumar AM, Rewari B, Harries AD, Zachariah R. The journey to antiretroviral therapy in Karnataka, India: who was lost on the road?. Journal of the International AIDS Society. doi: 10.7448/IAS.16.1.18502
21. Khanna A, lohya S, Sharath BN, Harries AD. Characteristics and treatment response in patients with tuberculosis and diabetes mellitus in Delhi, India. Public Health Action. 2013; 3(S1): S48–S50. doi: 10.5588/pha.13.0025
22. Kumpatla S, Sekar A, Achanta S, et al. Characteristics of patients with diabetes screened for tuberculosis in a tertiary care hospital in South India. Public Health Action. 2013; 3(S1): S23–S28. doi: 10.5588/pha.13.0035
23. Dave P, Shah A, Chauhan M, Screening patients with tuberculosis for diabetes mellitus in Gujarat, India. Public Health Action. 2013; 3(S1): S29–S33. doi: 10.5588/pha.13.0027
24. Achanta S, Tekumalla RR, Jaju J, et al. Screening Tuberculosis patients for Diabetes in a Tribal Tuberculosis Unit in South India. Public Health Action. 2013; 3(S1): S43–S47. doi: 10.5588/pha.13.0033
25. Jali MV, Mahishale VK, Hiremath MB, et al.Diabetes Mellitus and smoking among TB patients in a tertiary care centre in Karnataka, India. Public Health Action. 2013; 3(S1): S51–S53. doi: 10.5588/pha.13.0031
26. Harries AD, Satyanarayana S, Kumar AMV, et al. Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review. Public Health Action. 2013; 3(S1): S3–S9. doi: 10.5588/pha.13.0024
27. Singh V, Sharath BN. Updated National Guidelines for Pediatric Tuberculosis: Concerns Regarding Neurotuberculosis – Authors reply. Indian Pediatrics. 2013; 50: 800-01.
28. Singh V, Sharath BN. Updated National Guidelines for Pediatric Tuberculosis in India, 2012: Some Unresolved Issues – Authors reply. Indian Pediatrics. 2013. 50: 801-802.
29. Singh V, Sharath BN. Pediatric Tuberculosis – Authors reply. Indian Pediatrics. 2013; 50: 803.
30. Singh V, Sharath BN. Tuberculosis – A Quest Towards Objectivity – Authors reply. Indian Pediatrics. 2013; 50: 803-804.
31. Burugina NS, Menezes RG. Research publication in India faces new challenges. Lancet. 2013; 382:1484. doi: 10.1016/S0140-6736(13)62287-4
32. Sharath BN, Prakash S, Kumbhar S, et al. Employees state insurance corporation health camps at Bengaluru, India: Bridging gaps. Indian Journal of Occupational and Environmental Medicine. 2013; 17(2): 78–79. doi: 10.4103/0019-5278.123175
33. Nagaraja SB, Bansal AV, Kumar P. Implementation of External Quality Assessment (EQA) in RNTCP: Challenges and way forward. NTI Bulletin. 2013; 49/1&4.
34. Nagaraja SB, Menezes RG, Zachariah R. Open submission and open access: The right way ahead. Public Health Action. 2014; 4(1): 72. doi: 10.5588/pha.14.0003
35. Benchinmardi KK, Panduranga C, Srinivasamurthy V, et al. Haemotogical profile in acute dengue infection: A study at tertiary care teaching hospital. Journal of pharmaceutical and biomedical sciences (J Pharm Biomed Sci.) . 2013; 36(36):1866-1870.
36. Purabi Pukhan, Anandi, Sharath B N. Child health related Millennium Development Goals (MDGs): status of underfive children visiting a Well Baby Camp. International Journal of Medical Science and Public Health. 2014, 3(9).
37. Bansal AK, Kulshrestha N, Nagaraja SB, et al. Composite Indicator: new tool for monitoring Revised National Tuberculosis Control Programme performance in India. The International Journal of Tuberculosis and Lung Disease. 2014; 18(7): 840-842 doi: 10.5588/ijtld.13.0986
38. Abeygunawardena SC, Nagaraja SB, Bergh RV, Naik B, Pallewatte N, Masaima MNN. Management of previously treated TB patients in Kalutara district, Sri Lanka: how well do we fare? . Public Health Action. 2014; 4(2): 105-109. doi: 10.5588/pha.13.0111
39. Nagaraja SB, Menezes RG.The need to further augment the public health system to control tuberculosis. Lancet Global Health. 2014;2(7):e388. doi: 10.1016/S2214-109X(14)70246-3
40. Menezes RG, Tapa S, Pant S, et al. Publication Ethics. Medico Legal Journal. 2014.
41. Sathian B, Nagaraja SB, Banerjee I, et al. Awareness of Breast Cancer warning signs and screening methods among the female residents of Pokhara Valley, Nepal. Asia pacific journal of cancer prevention. 2014; 15: 4723-4726.
42. Somashekarappa D, Nagaraja SB, Menezes RG.Mental fitness certificates: are psychiatrists under dock? Indian Journal of Medical Ethics. 2014;11(4):260.
43. Nagaraja SB, Achanta S, Kumar AM, Satyanarayana S.Extending TB notification to the private sector in India: programmatic challenges? The International Journal of Tuberculosis and Lung Disease. 18(11):1353–1356. doi: 10.5588/ijtld.13.0836
44. Naveen Kotur, Sharath Burugina Nagaraja, Ritesh G Menezes. Weight of the liver and the spleen supplements inspirational activity . Medical Hypotheses. 2014; 83(3): 419. doi: 10.1016/j.mehy.2014.07.002
45. Nagaraja SB, Achanta S, Bansal A, Samyukta R. Tuberculosis control in India: Growing complexities for management. Public Health Action. 2014; 4(3): 205. doi: 10.5588/pha.14.0074
46. Das M, Isaakidis P, Van den Bergh R. HIV, multidrug-resistant TB, depression – when three diseases collide. Glob Health Action. 2014; 7: 24912. doi: 10.3402/gha.v7.24912
47. Shankar D, Kumar AM, Rewari B, et al. Retention in Pre-Antiretroviral Treatment care in a district of Karnataka, India: how well are we doing? Public Health Action. 2014; 4(4): 210-215. doi: 10.5588/pha.14.0073
48. Nagaraja SB, Shewade HD, Tripathy JP, Ajay Kumar MV. Public Private Imbroglio: why should TB patients suffer? Public Health Action. 2014; 4(4): 281. doi: 10.5588/pha.14.0094
49. Tripathi UC, Nagaraja SB, Tripathy JP, et al. Follow-up examinations: Are Multi Drug Resistant Tuberculosis patients in Uttar Pradesh, India on track? Public Health Action. 2015; 5(1) 59-64. doi: 10.5588/pha.14.0095
50. Kelamane S, Nagaraja SB, Kumar A, Satyanarayana S. Newer rapid TB diagnostic tests: Why the uptake is low in Indian private sector? Public Health Action. 2015; 5(1): 89. doi: 10.5588/pha.14.0108
51. Nagaraja SB, Menezes RG, Zachariah R, Wilson N. Ethics Approval: A Challenge for Public Health Researchers in India. Indian Journal of Medical Ethics. 2015; 12(2): 121-122.
52. Shewade HD, Govindarajan S, Sharath BN, et al. MDR-TB screening in a setting with molecular diagnostic technique: Who got tested, who didnt and why? . Public Health Action. 2015; 5(2): 132-139. doi: 10.5588/pha.14.0098
53. Sharath BN, Menezes RG, Hussain SA, Zachariah R. Can India be successful in eradicating TB just like polio? . Journal of Infection and public Health. 2015; 8: 389-391.
54. Hussain SA, Menezes RG, Nagaraja SB. Arrest of parents in Pakistan for refusal of polio vaccine: a necessary step. Lancet. 2015; 385(9977):1509. doi: 10.1016/S0140-6736(15)60751-6
55. Ilangovan K, Nagaraja SB, Ananthakrishnan R, Jacob AG, Tripathy JP, Tamang D.TB treatment delays in Odisha, India: Is it expected even after these many years of RNTCP implementation? PlosOne. 2015; 10(4): e0125465. doi: 10.1371/journal.pone.0125465
56. Sharath BN, Shilpashree MK, Menezes RG, Bansal AK. TB research in Indian medical colleges: Has it taken a backseat? Public Health Action. 2015; 5(3): 202. doi: 10.5588/pha.15.0023
57. Shastri S, Nagaraja SB, Tripathy JP, Satyanarayana S, Rewari BB. Predictors and Timing of ATT Initiation among HIV-TB Patients at ART Centers of Karnataka, India: Two Year Follow-Up. Plos One. 2015; 10(9): e0138603. doi: 10.1371/journal.pone.0138603
58. Vani BR, Kumar D, Sharath BN , Murthy VS, Geethamala K. A comprehensive study of prostate pathology in correlation with prostate‑specific antigen levels: An Indian study. Clinical Cancer Investigation Journal. 2015; 4(5). doi: 10.4103/2278-0513.164722
59. Sharath BN, Kumar A, Ranjini R, et al. How better is random blinded re-checking results in revised national TB Control Programme, India? Indian J Med Microbiol. 2015; 33: 572-575. doi: 10.4103/0255-0857.167318
59. Sharath BN, Kumar A, Ranjini R, et al. How better is random blinded re-checking results in revised national TB Control Programme, India? Indian J Med Microbiol. 2015; 33: 572-575. doi: 10.4103/0255-0857.167318
60. Nagaraja SB. Counting tuberculosis patients in India: A continued imbroglio? Public Health Open J. 2016; 1(3): e4-e5. doi: 10.17140/PHOJ-1-e003